Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Yaron Weber is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/28/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/21/2024 | AMGN | Buy Now | Amgen | $304.52 | 25.77% | Yaron Weber41% | $381 → $383 | Maintains | Buy | Get Alert |
| 08/07/2024 | AMGN | Buy Now | Amgen | $304.52 | 25.11% | Yaron Weber41% | $360 → $381 | Maintains | Buy | Get Alert |
| 04/17/2024 | AMGN | Buy Now | Amgen | $304.52 | 18.22% | Yaron Weber41% | $370 → $360 | Maintains | Buy | Get Alert |
| 02/28/2023 | BGNE | Buy Now | BeiGene | — | — | Yaron Weber41% | $213 → $262 | Maintains | Outperform | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $304.52 | -5.1% | Yaron Weber41% | $307 → $289 | Maintains | Outperform | Get Alert |
| 03/08/2021 | NUVB | Buy Now | Nuvation Bio | $1.87 | — | Yaron Weber41% | — | Initiates | → Outperform | Get Alert |
| 02/08/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $635.83 | -11.14% | Yaron Weber41% | $684 → $565 | Maintains | Outperform | Get Alert |
| 12/20/2019 | AMGN | Buy Now | Amgen | $304.52 | -9.04% | Yaron Weber41% | $253 → $277 | Maintains | Outperform | Get Alert |
